key: cord-0952850-7y3hv803
authors: Capecchi, Pier Leopoldo; Lazzerini, Pietro Enea; Brillanti, Stefano
title: Comment to the letter of Bril F et al. “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?”
date: 2021-05-05
journal: J Hepatol
DOI: 10.1016/j.jhep.2021.04.039
sha: 1b425b46825886a4a89a9de53c035016ffa399f7
doc_id: 952850
cord_uid: 7y3hv803

nan

Conversely, autoimmune diseases are rather commonly observed to present in the postpartum period 4,5 , particularly tyroiditis 6 and rheumatoid arthritis 4 . Nevertheless several cases of autoimmune hepatitis (AIH) have also been reported 7, 8, 9 and the addition of such a disease to the list of autoimmune conditions that may first present after pregnancy has been suggested 9 .

Thus, we wonder whether in the case report of Bril et al., the recent pregnancy rather than the administration of the COVID-19 vaccine is the event to possibly associate with the development of AIH. In favour of such a hypothesis also stands the time of J o u r n a l P r e -p r o o f latency before clinical presentation which is more consistent with pregnancy as the causative event. In fact, symptoms of postpartum AIH have been reported to occur from few days to one year after delivery, usually within 4 month9,10, but cases with early appearance are often difficult to differentiate from non-autoimmune pregnancyassociated liver damage10.

In this sense, we agree with the authors that in terms of pharmacovigilance the case can be appropriately reported as AIH as a possible expression of a vaccine-related adverse event/reaction. However, the concomitant history of a recent pregnancy represents a tremendous confounding factor, not contributing to solve the dilemma whether vaccine is causality or casualty.

Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) Vaccine: Causality or casualty?

Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction

Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?

Pregnancy and autoimmune diseases

Pregnancy and autoimmune connective tissue diseases

Postpartum thyroiditis

Acute seronegative autoimmune hepatitis in the post-partum period

Development of anti-centromere antibody-positive autoimmune hepatitis after childbirth

Severe Autoimmune Hepatitis First Presenting in the Early Post Partum Period

Development of liver dysfunction after delivery is possibly due to postpartum autoimmune hepatitis. A report of three cases